About this trial
Propofol is a commonly used intravenous anesthetic agent, but its administration is frequently associated with injection pain, causing patient discomfort and agitation. Various pharmacological agents have been used to reduce this pain, including nalbuphine and lidocaine; however, results from previous studies remain conflicting. This randomized clinical trial aims to compare the effectiveness of intravenous nalbuphine versus intravenous lidocaine in reducing the frequency of propofol-induced injection pain in patients undergoing elective general surgery procedures.
Eligibility criteria
Qualifiers
Age 18-60 years
Either male or female
ASA physical status I or II
Scheduled for elective general surgery under general anesthesia using propofol
Disqualifiers
Known hypersensitivity to propofol, nalbuphine, or lidocaine
Emergency surgery
Use of analgesics prior to surgery
Pregnant women
Trial design
Treatments tested in this trial
- Nalbuphine
- Lidocaine